[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100442271":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":22,"centralContacts":26,"locations":36,"responsibleParty":51,"collaborators":10,"id":53,"slug":10,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"University Hospital, Toulouse","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"patients initiating a biotherapy or a target treatment",null,"Blood sampling",[13],"Biological: Blood sampling",{"label":15,"type":10,"description":11,"interventionNames":16},"patients with chronic inflammatory rheumatism, weakening osteopathy or mechanical pathology",[13],[18],{"type":19,"name":11,"description":20,"armGroupLabels":21,"otherNames":10},"BIOLOGICAL","4 tubes of 7 mL will be sampled",[9,15],[23],{"name":24,"affiliation":5,"role":25},"Adeline RUYSSEN-WITRAND, MD","PRINCIPAL_INVESTIGATOR",[27,32],{"name":24,"role":28,"phone":29,"phoneExt":30,"email":31},"CONTACT","561775626","0033","ruyssen-witrand.a@chu-toulouse.fr",{"name":33,"role":28,"phone":34,"phoneExt":30,"email":35},"Delphine THUILLEZ","561776966","thuillez.d@chu-toulouse.fr",[37],{"facility":38,"status":39,"city":40,"state":10,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Purpan University Hospital","RECRUITING","Toulouse","31059","France",{"type":44,"coordinates":45},"Point",[46,47],1.44367,43.60426,{"lat":47,"lon":46},[50],{"name":24,"role":28,"phone":29,"phoneExt":30,"email":31},{"type":52,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100442271",false,"NCT05039216","Biobank for Inflammatory Chronic Diseases and Osteoporosis","Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse","BIOTOUL","Inclusion Criteria:\n\n* Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis\n* With National Health Assurance\n* Able to consent to the study\n\nExclusion Criteria:\n\n* Pregnancy or breastfeeding\n* Not able to give a consent\n* Severe anemia (Hb\\\u003C10g\u002FL)","ALL","18 Years","99 Years",{"count":64,"type":65},2000,"ESTIMATED","OBSERVATIONAL","The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.",[69,70,71,72],"Rheumatoid Arthritis","Psoriatic Arthritis","Spondyloarthritis","Osteoporosis","2026-03-16",{"date":75,"type":76},"2026-03-19","ACTUAL",{"date":78,"type":76},"2021-09-13",{"date":80,"type":65},"2031-09-01",{"name":5,"class":6},1]